United Therapeutics SG&A Expense (Annual) Trends

United Therapeutics Corp (UTHR)

318.55 -0.49 (-0.15%) USD | NASDAQ | Jun 26, 10:39

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1998. Upgrade now.

Date	Value
December 31, 2023	477.10M
December 31, 2022	482.10M
December 31, 2021	467.00M
December 31, 2020	423.90M
December 31, 2019	336.20M
December 31, 2018	265.80M
December 31, 2017	330.10M
December 31, 2016	316.80M
December 31, 2015	452.70M
December 31, 2014	381.30M
December 31, 2013	394.01M
December 31, 2012	201.75M
December 31, 2011	156.48M

Date	Value
December 31, 2010	188.61M
December 31, 2009	176.34M
December 31, 2008	94.31M
December 31, 2007	99.03M
December 31, 2006	54.03M
December 31, 2005	24.66M
December 31, 2004	21.53M
December 31, 2003	22.67M
December 31, 2002	15.89M
December 31, 2001	16.94M
December 31, 2000	11.74M
December 31, 1999	5.00M
December 31, 1998	2.40M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

336.20M

Minimum

2019

482.10M

Maximum

2022

437.26M

Average

467.00M

Median

2021

SG&A Expense (Annual) Benchmarks